Table 3.
Univariable | Multivariable | |||||||
Coefficient | P value | 95% CI | Coefficient | P value | 95% CI | |||
Age | ||||||||
Per 10-year older | −0.034 | 0.002 | −0.06 | −0.01 | −0.03 | <0.001 | −0.05 | −0.01 |
Sex | ||||||||
Female | 1 (ref) | |||||||
Male | 0.02 | 0.6 | −0.06 | 0.09 | −0.04 | 0.14 | −0.09 | 0.01 |
Ethnicity | ||||||||
White | 1 (ref) | |||||||
Asian | 0.01 | 0.7 | −0.06 | 0.09 | ||||
Black | −0.22 | 0.009 | −0.38 | −0.05 | ||||
Mixed | 0.07 | 0.5 | −0.13 | 0.26 | ||||
Other | −0.07 | 0.4 | −0.23 | 0.09 | ||||
Role | ||||||||
Nurse/HCA | 1 (ref) | |||||||
Doctor | 0.1 | 0.1 | −0.02 | 0.22 | ||||
Administrative staff | 0.07 | 0.1 | −0.01 | 0.15 | ||||
OT/PT/SLT | 0.11 | 0.1 | −0.03 | 0.26 | ||||
Laboratory staff | 0.24 | 0.002 | 0.09 | 0.39 | ||||
Porter or domestic worker | −0.23 | 0.03 | −0.44 | −0.03 | ||||
Medical or nursing student | 0.07 | 0.7 | −0.26 | 0.4 | ||||
Other | −0.06 | 0.1 | −0.14 | 0.01 | ||||
BMI | ||||||||
<16 | −0.13 | 0.7 | −0.8 | 0.53 | ||||
16–24.9 | 1 (ref) | |||||||
25–29.9 | −0.06 | 0.1 | −0.12 | 0.01 | ||||
30–34.9 | 0.01 | 0.9 | −0.08 | 0.09 | ||||
35–39.9 | 0.01 | 0.9 | −0.12 | 0.14 | ||||
40+ | 0.05 | 0.5 | −0.09 | 0.19 | ||||
Comorbidity | ||||||||
Yes vs no | ||||||||
Smoking | −0.17 | 0.003 | −0.29 | −0.06 | −0.06 | 0.12 | −0.14 | 0.02 |
Pregnant | 0.13 | 0.3 | −0.11 | 0.37 | ||||
Asthma | 0.005 | 0.9 | −0.15 | 0.04 | ||||
Hypertension | −0.06 | 0.2 | −0.15 | 0.03 | −0.06 | 0.09 | −0.12 | 0.01 |
Thyroid disorder (excluding malignancy) | 0.01 | 0.9 | −0.09 | 0.11 | 0.05 | 0.13 | −0.02 | 0.12 |
Diabetes | −0.14 | 0.03 | −0.26 | −0.01 | −0.14 | <0.001 | −0.22 | −0.05 |
Immunosuppression | −0.38 | <0.001 | −0.51 | −0.25 | −0.22 | <0.001 | −0.31 | −0.13 |
Psoriasis | −0.13 | 0.1 | −0.3 | 0.04 | ||||
Heart disease | 0.05 | 0.6 | −0.14 | 0.25 | ||||
Non-haematological malignancy | 0.14 | 0.1 | −0.04 | 0.32 | 0.13 | 0.04 | 0.01 | 0.25 |
Rheumatological disorder | −0.28 | 0.01 | −0.5 | −0.06 | ||||
Respiratory disease (excluding asthma) | −0.22 | 0.02 | −0.41 | −0.03 | −0.17 | 0.01 | −0.3 | −0.04 |
Haematological disease (excluding malignancy) | 0.06 | 0.6 | −0.14 | 0.25 | ||||
Liver disease | −0.03 | 0.9 | −0.38 | 0.32 | ||||
Neurological disorder | −0.001 | 0.9 | −0.33 | 0.33 | ||||
CKD stage 3, 4 or 5 | −0.84 | <0.001 | −1.3 | −0.37 | ||||
Lupus | −0.68 | 0.002 | −1.1 | −0.24 | ||||
Splenic disorder (excluding traumatic splenectomy) | −0.42 | 0.2 | –1 | 0.15 | ||||
Haematological malignancy | 0.13 | 0.7 | −0.53 | 0.79 | ||||
Organ transplant | −3.06 | <0.001 | −3.55 | −2.57 | −2.66 | <0.001 | −3.01 | −2.31 |
Vaccination | ||||||||
BNT162b2/BNT162b2 | ||||||||
ChAdOx1/ChAdOx1 | −0.9 | <0.001 | −0.95 | −0.85 | −0.91 | <0.001 | −0.96 | −0.87 |
Evidence of COVID-19 infection at baseline (yes vs no) | 0.25 | <0.001 | 0.18 | 0.33 | 0.29 | <0.001 | 0.24 | 0.34 |
COVID-age score | ||||||||
Per 10 score higher | −0.05 | <0.001 | −0.06 | −0.03 |
Bold indicates a significant p value of <0.05. The outcome was modelled in log10 scale. Variables in the multivariable model were selected using backward selection by Akaike information criteria.
BMI, body mass index; CKD, chronic kidney disease; HCA, healthcare assistant; OT/PT/SLT, occupational therapist, physiotherapist, and speech and language therapist.